BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2014 | $260,000 | Replaced |
| 2nd Quarter - Amendment | Sep 21, 2015 | $150,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R.436, Protect Medical Innovation Act Issues related to corporate tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
| ELIZABETH WOODY | — |
Health Issues HCR
Issues related to safe handling of hazardous drugs Issues related to FDA regulation of generic drugs Issues related to pandemic preparedness
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
| ELIZABETH WOODY | — |
Medicare/Medicaid MMM
S.672, Medicare Safe Needle Disposal Coverage Act of 2013 H.R.4302 (PL 113-93), Protecting Access to Medicare Act of 2014 Issues related to reimbursement for flow cytometry
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
| DANNY LY | — |
Budget/Appropriations BUD
S.2407, 21st Century Global Health Technology Act of 2014 NIH funding PEPFAR funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER M LURAY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.